Comparative Pharmacology

Head-to-head clinical analysis: CHLORPHENIRAMINE MALEATE versus PROMETHAZINE.

Peer-Reviewed Evidence

Differential Analysis

CHLORPHENIRAMINE MALEATE vs PROMETHAZINE

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

CHLORPHENIRAMINE MALEATE

Antihistamine

Category C

PROMETHAZINE

Antihistamine / Antiemetic

Category A/B

Head-to-Head

Clinical Matrix

Mechanism of Action

H1 receptor antagonist; competitively blocks histamine at H1 receptors, preventing histamine-mediated symptoms such as vasodilation, increased capillary permeability, and smooth muscle contraction.

Promethazine is a phenothiazine derivative that acts as a potent histamine H1 receptor antagonist, thereby blocking the effects of histamine. It also has central anticholinergic, antiemetic, and sedative properties, likely mediated through antagonism at muscarinic, dopamine D2, and serotonin receptors in the brain.

Clinical Dosing

4 mg orally every 4-6 hours, not to exceed 24 mg per day; or 10-20 mg intramuscularly or intravenously as a single dose, not to exceed 40 mg per day.

12.5-25 mg IM or IV every 4-6 hours; also 25 mg PO or PR every 6-8 hours. Maximum 100 mg/day.

Direct Interaction

None Documented

Half-Life

Other Significant Interactions

Clinical Note

moderate

Dexchlorpheniramine maleate + Haloperidol

"The metabolism of Haloperidol can be decreased when combined with Dexchlorpheniramine maleate."

Clinical Note

moderate

Promethazine + Risedronic acid

"Promethazine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects."

Clinical Note

moderate

Promethazine + Methylphenidate

"Promethazine can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects."

Clinical Note